NYSE ARCA | ETF
In seeking to track the performance of the S&P Biotechnology Select Industry Index (the index), the fund employs a sampling strategy.
It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index.
The index represents the biotechnology segment of the S&P Total Market Index (S&P TMI).
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 2.05% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 1.85% |
| ROIV | Roivant Sciences Ltd | Healthcare | Biotechnology | 1.64% |
| MIRM | Mirum Pharmaceuticals Inc | Healthcare | Biotechnology | 1.58% |
| RVMD | Revolution Medicines Inc | Healthcare | Biotechnology | 1.52% |
| PCVX | Vaxcyte Inc | Healthcare | Biotechnology | 1.50% |
| MTSR | Metsera, Inc. Common Stock | Healthcare | Biotechnology | 1.48% |
| FOLD | Amicus Therapeutics Inc | Healthcare | Biotechnology | 1.48% |
| PRAX | Praxis Precision Medicines Inc | Healthcare | Biotechnology | 1.46% |
| ALKS | Alkermes Plc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.44% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 1.44% |
| BMRN | Biomarin Pharmaceutical Inc | Healthcare | Biotechnology | 1.43% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 1.43% |
| KRYS | Krystal Biotech Inc | Healthcare | Biotechnology | 1.42% |
| HALO | Halozyme Therapeutics Inc | Healthcare | Biotechnology | 1.40% |
| AKRO | Akero Therapeutics Inc | Healthcare | Biotechnology | 1.38% |
| CYTK | Cytokinetics Inc | Healthcare | Biotechnology | 1.36% |
| SWTX | SpringWorks Therapeutics Inc | Healthcare | Biotechnology | 1.36% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 1.31% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 1.30% |